Clinical Trial Update: Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial investigating how ramipril may affect the onset of type 2 diabetes in individuals with metabolic syndrome; the study was terminated with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ramipril (ramipril)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Metabolic Syndrome | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2016-01-15